Concord Medical Services has announced the preliminary opening of Datong Meizhongjiahe Cancer Hospital in China.

The100-bed hospital houses advanced radiotherapy and diagnostic imaging equipment such as linear accelerator and MRI.

This registered Level-II speciality cancer hospital offers radiation, imaging, laboratory testing, inpatient, and nursing services.

Concord Medical chairman and CEO Dr. Jianyu Yang said: "This first wholly-owned domestic cancer hospital in China is an important step of our broad strategy to build a nationwide chain of free-standing cancer treatment and diagnosis centres under the brand "Meizhongjiahe" in the future.

"Currently, the healthcare reform has touched upon many historically challenging issues, such as multi-location practice for doctors and equipment licensing to private hospitals. We will capitalize on this growing opportunity and rely on our excellent doctor resources as well as strong medical network to contribute to the improvement of overall level of cancer treatment and diagnosis in China, generating long-term and stable returns for our shareholders."

Currently, Concord is working on the establishment of speciality cancer hospitals in cities such as Wuxi, Hangzhou, Taizhou, and Nanchang, as it seeks to expand in the domestic market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Through its Meizhongjiahe network, the company will provide advanced, best-practice diagnostic and treatments for patients in Tier II and Tier III cities.